Groundbreaking Malaria Vaccine under Test
Why in news?
- The World Health Organisation welcomed a pilot project in Malawi of administering a malaria vaccine to children below the age of 2 years. A total 3,60,000 children across three African countries — Malawi, Ghana and Kenya — will be covered every year with the vaccine.
What is the RTS, S (Mosquirix) vaccine?
- RTS, S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine.
- A pilot project for vaccination has been launched on April 23, 2019 in Malawi. Ghana and Kenya are to join the program later this year.
- The vaccine has been developed by GSK (GlaxoSmithKline ) ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Biodiversity Loss and Climate Change: Understanding the Feedback Loop
- 2 Concentration of Exports in Developed States: Implications for Inclusive Growth
- 3 Bioremediation: Answer to India’s Solid Waste Challenge
- 4 Decoding Regulations and Structural Gaps in India’s Civil Aviation Sector
- 5 India’s Biosecurity Imperatives: Securing Health and the Nation
- 6 From Solar Power to Solar Waste: India’s Emerging Concern
- 7 India-Oman CEPA: A Strategic Reset in the Gulf
- 8 Transforming India into a Leading Quantum-Powered Economy
- 9 Inhalable Microplastics: India’s Emerging Health Threat
- 10 NFSI 2025-30: Accelerating Equitable Financial Prosperity
